![Acelity V.A.C.ULTA Скачать руководство пользователя страница 10](http://html2.mh-extra.com/html/acelity/v-a-c-ulta/v-a-c-ulta_safety-information-and-application-instructions_3939654010.webp)
10
Non-clinical testing under these same conditions produced a temperature rise of <0�4°C� MR image
quality may be compromised if the area of interest is in the same area or relatively close to the position of
the V�A�C� GranuFoam Silver® dressing�
Hyperbaric Oxygen Therapy (HBO):
Do not take the V�A�C�Ulta™ Therapy Unit into a hyperbaric oxygen
chamber� The V�A�C�Ulta™ Therapy Unit is not designed for this environment,
and should be considered
a fire hazard
� After disconnecting the V�A�C�Ulta™ Therapy Unit, either (i) replace the V�A�C�® Dressing or
V�A�C� VeraFlo™ Therapy Dressing with another HBO compatible material during the hyperbaric treatment,
or (ii) cover the unclamped end of the V�A�C�® Tubing with dry gauze� For HBO therapy, the V�A�C�® Tubing
or V�A�C� VeraFlo™ Therapy tubing must not be clamped� Never leave a V�A�C�® Dressing in place without
active V�A�C�® Therapy for more than two hours (refer to the
Keep V.A.C.® Therapy On
section)�
NOTE:
If using V.A.C. VeraFlo™ Therapy ensure that irrigation fluid or treatment
solutions are fully removed from the dressing prior to stopping negative pressure
wound therapy.
ADDITIONAL WARNINGS FOR V.A.C. VERAFLO™ THERAPY
Topical Wound Solutions:
Topical wound solutions or suspensions may enter internal
body cavities if the wound is open to such cavities� They should not be infused into
wounds with unexplored tunnels or unexplored undermining as they may enter into
unintended cavities�
Pauses in Negative Pressure:
Application of V�A�C� VeraFlo™ Therapy will result in pauses
of negative pressure wound therapy, which is not recommended on wounds requiring
continuous V�A�C�® Therapy� Do not use V�A�C� VeraFlo™ Therapy over unstable structures,
such as unstable chest wall or non-intact fascia, on patients at increased risk of bleeding,
highly exudating wounds, on flaps, grafts or wounds with acute enteric fistulae�
Bioengineered Tissue:
V�A�C� VeraFlo™ Therapy is not intended for use with cellular or
acellular bioengineered tissues�
Hemostasis:
Patients with difficult or fragile wound hemostasis are at increased risk of
bleeding associated with V�A�C� VeraFlo™ Therapy due to the potential for disruption of
clots or dilution of clotting factors� Do not use V�A�C� VeraFlo™ Therapy where hemostatic
agents have been used in the wound bed�
V.A.C.ULTA™ THERAPY SYSTEM PRECAUTIONS
Standard Precautions:
To reduce the risk of transmission of bloodborne pathogens, apply standard
precautions for infection control with all patients, per institutional protocol, regardless of their diagnosis
or presumed infection status� In addition to gloves, use gown and goggles if exposure to body fluids is
likely�
Содержание V.A.C.ULTA
Страница 2: ...EN...
Страница 29: ...29...
Страница 32: ...DE...
Страница 59: ...59...
Страница 62: ...62 NL...
Страница 89: ...89...
Страница 92: ...FR...
Страница 119: ...119...
Страница 122: ...IT...
Страница 149: ...149...
Страница 152: ...ES...
Страница 179: ...179...
Страница 182: ...DA...
Страница 209: ...209...
Страница 212: ...SV...
Страница 239: ...239...
Страница 242: ...PT BR...
Страница 269: ...269...
Страница 272: ...TR...
Страница 299: ...299...
Страница 301: ...EL V A C ULTA V A C ULTA V A C VERAFLO V A C Ulta KCI Rx Only...
Страница 302: ...EL...
Страница 307: ...307 V A C V A C VeraFlo V A C VeraFlo V A C V A C VeraFlo 1000 mL 1000 mL...
Страница 317: ...317 3M Cavilon 3M Cavilon 3M Cavilon V A C Advanced 3M Cavilon 5 6 7...
Страница 318: ...318 V A C VERAFLO V A C 1 2 V A C VeraFlo 2 V A C VeraFlo V A C VeraFlo 3 V A C VeraFlo 3 4 4 2 4 4 5 3A 3B...
Страница 326: ...326 V A C VERAFLO 1 2 25 mmHg 30 5 cm 2 5 cm 3 cm 28 29 30 31 32 33 34 35 36 37 38...
Страница 328: ...328 V A C VERAFLO 1 V A C VeraFlo 2 V A C VeraT R A C 39 39...
Страница 329: ...329...
Страница 330: ...330 3M Tegaderm Cavilon 3M Corporation KCI Licensing Inc Copyright 2017 KCI Licensing Inc 417670 Rev A 10 2017...
Страница 332: ...FI...
Страница 359: ...359...
Страница 362: ...362 NO...
Страница 389: ...389...
Страница 395: ...395...